Correlation Between Shanghai Rongtai and Shanghai Rightongene

Can any of the company-specific risk be diversified away by investing in both Shanghai Rongtai and Shanghai Rightongene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shanghai Rongtai and Shanghai Rightongene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Shanghai Rongtai Health and Shanghai Rightongene Biotechnology, you can compare the effects of market volatilities on Shanghai Rongtai and Shanghai Rightongene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shanghai Rongtai with a short position of Shanghai Rightongene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shanghai Rongtai and Shanghai Rightongene.

Diversification Opportunities for Shanghai Rongtai and Shanghai Rightongene

0.75

Correlation Coefficient

Shanghai Rongtai  Shanghai Rightongene

Poor diversification

The 3 months correlation between Shanghai and Shanghai is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Rongtai Health and Shanghai Rightongene Biotechno in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Rightongene and Shanghai Rongtai is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shanghai Rongtai Health are associated (or correlated) with Shanghai Rightongene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Rightongene has no effect on the direction of Shanghai Rongtai i.e., Shanghai Rongtai and Shanghai Rightongene go up and down completely randomly.

Pair Corralation between Shanghai Rongtai and Shanghai Rightongene

Assuming the 90 days trading horizon Shanghai Rongtai Health is expected to generate 0.64 times more return on investment than Shanghai Rightongene. However, Shanghai Rongtai Health is 1.57 times less risky than Shanghai Rightongene. It trades about -0.15 of its potential returns per unit of risk. Shanghai Rightongene Biotechnology is currently generating about -0.18 per unit of risk. If you would invest  1,508  in Shanghai Rongtai Health on October 9, 2024 and sell it today you would lose (132.00) from holding Shanghai Rongtai Health or give up 8.75% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Shanghai Rongtai Health  vs.  Shanghai Rightongene Biotechno

Shanghai Rongtai Health

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shanghai Rongtai Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Shanghai Rongtai is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Shanghai Rightongene

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shanghai Rightongene Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Shanghai Rightongene is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Shanghai Rongtai and Shanghai Rightongene

The main advantage of trading using opposite Shanghai Rongtai and Shanghai Rightongene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shanghai Rongtai position performs unexpectedly, Shanghai Rightongene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Rightongene will offset losses from the drop in Shanghai Rightongene's long position.

The idea behind Shanghai Rongtai Health and Shanghai Rightongene Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.